Navigation Links
Partnership for Safe Medicines Arms Public Against Counterfeit Drugs
Date:12/1/2008

Consumer protection group's new resource helps Americans cut prescription costs without compromising drug safety

WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- A collection of online educational materials are now available for free to consumers to help fend off the dangers of contaminated or counterfeit drugs. Unveiled today by the Partnership for Safe Medicines, "Consumer Resources" is designed to help consumers ensure the safety of their prescription drugs and includes guides on safely purchasing medicines online and how to save money without compromising drug safety.

As incidents of unscrupulous producers cutting food and medical goods with foreign, even toxic, materials become increasingly apparent across the globe, the Partnership for Safe Medicines, a coalition of organizations and individuals, is leading the effort to protect consumers from counterfeit medicines.

"Each day, innocent people unknowingly risk death or serious injury to their health by taking counterfeit drugs," said Marv D. Shepherd, Ph.D., president of the Partnership for Safe Medicines and renowned expert on drug importation and drug counterfeiting. "All across the world, we are seeing more occurrences of counterfeits involving more types of drugs in more countries. The makers of counterfeit drugs have enjoyed and profited from loopholes in our distribution system designed to deliver healthy medicines to those in need."

Available on the Partnership's Web site (www.SafeMedicines.org),"Consumer Resources" provides visitors with tips for identifying common warning signs of rogue online pharmacies, advice for recognizing when a drug is counterfeit, and counsel for making safe online drug purchases. The materials also provide practical information on how to save money on prescription drugs.

Thomas T. Kubic, president and C
'/>"/>

SOURCE Partnership for Safe Medicines
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Molecular partnership controls daily rhythms, body metabolism
2. JavaFit, Distributors of Vitamin Infused Fresh Roasted Coffee, Announces Partnership With CLR Roasters
3. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
4. Tigermed Forms Strategic Partnerships With Leading CROs in Russia and South Korea
5. First Lady Laura Bushs Partnership for Breast Cancer Awareness and Research Extends to Panama
6. First Lady Laura Bushs Partnership for Breast Cancer Awareness and Research extends to Panama
7. ReachMD Announces New Strategic Partnership with American Medical Directors Association
8. Care Improvement Plus Recognized with Metropolitan Partnership in Aging Award
9. Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center
10. Elsevier announces launch of PM&R in partnership with the AAPM&R
11. Seattle University in Partnership With the Opus Prize Foundation Award $1 Million Opus Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... ReverseAges.com launches new content to includ...atigue, and how to best deal with these health iss...EB) July 3, 2009 -- ReverseAges.com has recently l... the dangers of common health issues such as high ... variety of factors, and the new content on Revers...
(Date:7/2/2009)...ore,s Bioprocessing Technology Institute (BTI) hav...apoptosis inhibitory molecule" (FAIM), protects bo...ammed cell death. , Their research is published...ation . , The scientists, Jianxin Huo, Ph.D., an...cess may possibly be manipulated for clinical appl...
(Date:7/2/2009)...., July 2 Dr Daniel Goldberg, a le... new study to measure the effectiveness of using 5...- a common, worldwide, highly contagious and often...for long term visual impairment due to corneal inv... are invited to register to participate in the Bet...
(Date:7/2/2009)...ts down one set of neurons, another set wakes up: ...ews) -- New information about brain circuit activi...leep aid Ambien (zolpidem) walk, eat, talk on the ...without remembering it the next morning. , The ...ious patients into a conscious state. , In expe...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2Health News:Odd Behaviors on Ambien Linked to Brain Circuitry 2
...to the fire itself, the burning problem, being the...forced Government directives to disclose levels of...l method to test levels of trans fat in french fri...vantage, revealing that they contain one third mor...
...essor of radiology at the University of Iowa Roy J...that using positron emission tomography (PET) tech... cancer to the treatment being provided. Juweid a...Lombardi Comprehensive Cancer Center at Georgetown...
...ary issue of the Journal of Periodontology, says t...isk of developing preeclampsia in pregnancy. // Th...ptic mothers have low birth weight babies as compa...ia. "We found that chronic periodontitis was more ...
...e Indian State of Madhya Pradesh has been chained ...lness. // He spends most of time in a motionless s...as chained after he started attacking family membe... any reason, says his brother Bhogchand, a farmer....
Other Medicine News:Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2
(Date:6/30/2009)..., MIDLOTHIAN, Va., June 30 In tw...LC Plus nebulizer and PRONEB compressors (Ultra an...terol fumarate (Perforomist, DEY LP, Mylan Inc.) i...d that researchers chose PARI products as the excl...ng maintenance treatments for COPD. Sutherland et...
(Date:6/30/2009)..., AMSTERDAM, The Netherlands, June 30 /PRNew...t on the Decision-Making Process With,Respect to ...conomic analysis presented today at this year,s,E...gy (ESHRE) congress showed,that, within the param...fertilisation (IVF) treatment MENOPUR (highly-puri...
(Date:6/29/2009)..., aTyr Pharma Targets for Novel Biotherapeutics ..., SAN DIEGO, June 29 Pangu BioPha...ay announced the filing of its third patent applic...d human tRNA synthetases. Although tRNA synthetas...in synthesis machinery found in all organisms, hum...
(Date:6/28/2009)..., CHIPPENHAM, England and TOKYO, June 29 /PR...tones for Both Companies , Sosei Group Corp...tura,Group plc ("Vectura"; LSE: VEC) announce the...vartis, with NVA237, a once-daily, long-acting mus...ronic obstructive pulmonary disease,(COPD). NVA23...
Breaking Medicine Technology:PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 1Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 2Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 3Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 4Sangamo BioSciences and Sigma Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock Out Cell Lines 1579 5HeartWare Selects Allen 26 Caron for Investor Relations and Corporate Communications 14923 1HeartWare Selects Allen 26 Caron for Investor Relations and Corporate Communications 14923 2STMicroelectronics and Veredus Laboratories Launch Markets First Lab on Chip for Rapid Molecular Flu Detection at Point of Need 14920 1STMicroelectronics and Veredus Laboratories Launch Markets First Lab on Chip for Rapid Molecular Flu Detection at Point of Need 14920 2STMicroelectronics and Veredus Laboratories Launch Markets First Lab on Chip for Rapid Molecular Flu Detection at Point of Need 14920 3Therapeutic cloning treats Parkinsons disease in mice 14916 1
...I Intergroupe Francophone du Myelome (IFM),Trial P...2007 /PRNewswire-FirstCall/ --,Millennium Pharmace...esented on the comparative Phase III clinical tria...nosed multiple myeloma (MM),patients. As induction... the VELCADE based therapy produced a high complet...
...ine for Second Pivotal Phase 3 Trial CL-05, CHICAG...d Life,Sciences Holdings, Inc. , today announced t... Trial CL-06, the first of two,pivotal Phase 3 cli...ectiveness of cethromycin, a novel once-a-day anti...eumonia (CAP). The Company,also provided an update...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
PacePath is a comprehensive anatomic pathology software system that is the culmination of more than five years of development and testing by leading industry experts.
...ws NT client server system that combines unmatched...speed volume required to meet the most demanding l...Net is structured to make generating and distribut... Our system can upload lab activity to electronic ...
LabPak II is a comprehensive multi-user Laboratory Information System designed to meet the requirements of the larger POL, small hospital or private laboratory. It is the next step up from the LabPak
...tures a "U" fenestration with wide adhesive area. ...esion with no residue. Aggressive adhesive with no...are matte finish film and a split poly liner for e...tification. , ,Available sterile in a box of 10 or...
Medicine Products: